全文获取类型
收费全文 | 8234篇 |
免费 | 54篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 79篇 |
儿科学 | 327篇 |
妇产科学 | 170篇 |
基础医学 | 697篇 |
口腔科学 | 47篇 |
临床医学 | 561篇 |
内科学 | 1629篇 |
皮肤病学 | 175篇 |
神经病学 | 1372篇 |
特种医学 | 189篇 |
外国民族医学 | 1篇 |
外科学 | 1677篇 |
综合类 | 12篇 |
预防医学 | 373篇 |
眼科学 | 122篇 |
药学 | 249篇 |
中国医学 | 8篇 |
肿瘤学 | 606篇 |
出版年
2023年 | 297篇 |
2022年 | 536篇 |
2021年 | 416篇 |
2020年 | 541篇 |
2019年 | 449篇 |
2018年 | 409篇 |
2017年 | 242篇 |
2016年 | 229篇 |
2015年 | 290篇 |
2014年 | 586篇 |
2013年 | 468篇 |
2012年 | 412篇 |
2011年 | 300篇 |
2010年 | 380篇 |
2009年 | 333篇 |
2008年 | 199篇 |
2007年 | 328篇 |
2006年 | 268篇 |
2005年 | 249篇 |
2004年 | 150篇 |
2003年 | 133篇 |
2002年 | 161篇 |
2001年 | 161篇 |
2000年 | 102篇 |
1999年 | 116篇 |
1998年 | 80篇 |
1997年 | 61篇 |
1996年 | 72篇 |
1995年 | 24篇 |
1994年 | 21篇 |
1993年 | 19篇 |
1992年 | 16篇 |
1991年 | 15篇 |
1990年 | 10篇 |
1989年 | 13篇 |
1988年 | 11篇 |
1987年 | 17篇 |
1986年 | 11篇 |
1985年 | 24篇 |
1984年 | 19篇 |
1983年 | 18篇 |
1982年 | 20篇 |
1981年 | 23篇 |
1980年 | 14篇 |
1979年 | 14篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1975年 | 3篇 |
1974年 | 7篇 |
1973年 | 3篇 |
排序方式: 共有8294条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Digestive and liver disease》2022,54(5):645-653
BackgroundCombination of liver stiffness measurement and platelets count is a tool to safely rule out varices needing treatment (VNT) in patients with compensated advanced chronic liver disease (cACLD). Aims: to evaluate 4-year liver-related complications and survival in low-risk patients according to Baveno VI criteria.Methodswe conducted a monocentric retrospective analysis of prospectively collected data of all consecutive patients, with cirrhosis (LSM≥12.5 kPa) and without previous complication, evaluated between 2012 and 2015. Liver-related complications and survival were compared between 2 groups of patients: favourable (LSM< 20 kPa and platelet count>150.000/mm3) and unfavourable Baveno VI status patients (LSM ≥ 20 kPa or platelet count ≤150.000/mm3).Results455 patients with cACLD were analysed. Two hundred patients had favourable Baveno VI criteria, 3.6% with VNT. The 4-year probability of being free of acute decompensation was higher in low-risk patients (94.4 ± 1.8% vs. 85.7%±2.6%, p = 0.018). Unfavourable Baveno status was independently associated with acute decompensation. The probability of being free of HCC was significantly higher in low-risk patients (94.2 ± 1.8% vs. 87.6 ± 2.4%, p = 0.048). Liver-related mortality was not different between the 2 groups (p = 0.56).ConclusionThe Baveno VI criteria could predict clinical outcome in cACLD. 相似文献
4.
5.
6.
7.
8.
《Neuromuscular disorders : NMD》2022,32(1):25-32
Autoantibodies against 3?hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and the signal recognition particle (SRP) are representative antibodies causing immune-mediated necrotizing myopathies (IMNM), called as anti-HMGCR and anti-SRP myopathies, respectively. Here, we analyzed the differences in routine blood test results between 56 anti-HMGCR and 77 anti-SRP myopathy patients. A higher alanine transaminase (ALT) level and a lower aspartate transaminase (AST)/ALT ratio were observed in anti-HMGCR myopathy patients [ALT, 265.7 ± 213.3 U/L (mean ± standard deviation); AST/ALT ratio, 0.88 ± 0.32] than in anti-SRP-myopathy patients (ALT, 179.3 ± 111.2 U/L, p < 0.05; AST/ALT ratio, 1.28 ± 0.40, p < 0.01). In the active phase, anti-HMGCR myopathy often showed ALT predominance, whereas anti-SRP myopathy often showed AST predominance. In addition, there were differences in erythrocyte sedimentation rate (ESR), total cholesterol (TChol) level, and high-density lipoprotein (HDL) level between anti-HMGCR and anti-SRP myopathies (ESR: HMGCR, 24.4 ± 20.8 mm/1 h; SRP, 35.7 ± 26.7 mm/1 h, p = 0.0334; TChol: HMGCR, 226.7 ± 36.6 mg/dL; SRP, 207.6 ± 40.8 mg/dL, p = 0.0163; HDL: HMGCR, 58.4 ± 13.9 mg/dL; SRP, 46.2 ± 17.3 mg/dL, p < 0.01). Additional studies on the differences in routine blood test results may further reveal the pathomechanisms of IMNM. 相似文献
9.
10.
《Clinical genitourinary cancer》2022,20(1):95.e1-95.e6
IntroductionThis study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).Patients and MethodsRecords of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging.ResultsThe concordance between URS biopsy-based clinical and RNU pathological staging was 34.5%. Clinical understaging occurred in 59.5% patients. Upstaging to muscle-invasive disease occurred in 240 (41.7%) of 575 patients diagnosed with ≤cT1 disease. Of those diagnosed with muscle-invasive disease on final pathology, 89.6% had been clinically diagnosed with ≤cT1 disease. In the univariable analyses, computed tomography urography (CTU)–based invasion, ureter location, hydronephrosis, high-grade cytology, high-grade biopsy, sessile architecture, age, and women sex were significantly associated with pathological upstaging (P < .05). In the multivariable analyses, CTU-based invasion and hydronephrosis remained associated with pathological upstaging (P < .05). URS biopsy-based clinical and pathological gradings were concordant in 634 (54.2%) patients. Clinical undergrading occurred in 496 (42.4%) patients.ConclusionsClinical understaging/undergrading and upstaging to muscle-invasive disease occurred in a high proportion of UTUC patients undergoing RNU. Despite the inherent selection bias, these data underline the challenges of accurate UTUC staging and grading. In daily clinical practice, URS biopsy and CTU offer the most accurate preoperative information albeit with limited predictive value when used alone. These findings should be considered when utilizing preoperative, risk-adapted strategies. 相似文献